Summary: Spread and adoption of inventions and techniques from one geographic area to another, from one discipline to another, or from one sector of the economy to another. For example, improvements in medical equipment may be transferred from industrial countries to developing countries, advances arising from aerospace engineering may be applied to equipment for persons with disabilities, and innovations in science arising from government research are made available to private enterprise.
Publications193 found, 100 shown here
- Transfusion medicine technology transfer: traps to avoidPhilip Mendes
Technology Law, Brisbane, Australia
Transfus Med Rev 16:25-33. 2002b>Technology transfer is the process of commercializing technology and taking it from the laboratory to the marketplace. At some stage in the technology transfer process, a due diligence will be undertaken...
- Data-sharing and data-withholding in genetics and the life sciences: results of a national survey of technology transfer officersEric G Campbell
Harvard Medical School, Boston, MA, USA
J Health Care Law Policy 6:241-55. 2003
- HIV prevention technology transfer: challenges and strategies in the real worldRosemary C Veniegas
Center for HIV Identification, Prevention, and Treatment Services, University of California, Los Angeles, CA 90024, USA
Am J Public Health 99:S124-30. 2009..We examined implementation of evidence-based interventions for HIV prevention at community-based organizations in Los Angeles County, CA...
- Replicating effective programs: HIV/AIDS prevention technology transferM S Neumann
Division of HIV AIDS Prevention Intervention Research and Support, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
AIDS Educ Prev 12:35-48. 2000..The experience of the REP project indicates that technology transfer is complex. Interventions need to be adapted to local circumstances...
- Translational and clinical science--time for a new visionElias A Zerhouni
National Institutes of Health, USA
N Engl J Med 353:1621-3. 2005
- Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPVWilfried A M Bakker
National Institute for Public Health and the Environment, Vaccinology Unit, P O Box 1, 3720BA Bilthoven, The Netherlands
Vaccine 29:7188-96. 2011..Also, results will be shown from large-scale (to prepare for future technology transfer) generation of Master- and Working virus seedlots, and clinical trial material (for phase I studies) ..
- International technology transfer of a GCLP-compliant HIV-1 neutralizing antibody assay for human clinical trialsDaniel A Ozaki
Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America
PLoS ONE 7:e30963. 2012..As a result, several of the CAVD/CA-VIMC Regional Laboratories are now in the process of conducting or planning to conduct the GCLP-compliant TZM-bl NAb Assay as an indicator of vaccine immunogenicity for ongoing human clinical trials...
- Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCRL Dyrskjøt
Department of Molecular Medicine, Aarhus University Hospital, Skejby, Denmark
Br J Cancer 107:1392-8. 2012....
- The global access initiative at the University of British Columbia (UBC): Availability of UBC discoveries and technologies to the developing worldKishor M Wasan
The University of British Columbia, Faculty of Pharmaceutical Sciences, Division of Pharmaceutics and Biopharmaceutics, 2146 East Mall, Vancouver, B C, Canada V6T 123
J Pharm Sci 98:791-4. 2009..This commentary will discuss these principles and provide examples of where they have been applied to several UBC technologies...
- Inside the triple helix: technology transfer and commercialization in the life sciencesEric G Campbell
Harvard Medical School, USA
Health Aff (Millwood) 23:64-76. 2004..bias in the reporting of results, limited revenues from these activities, and the lack of data to evaluate technology transfer activities...
- The cost-effectiveness of technology transfer using telemedicineK Johnston
Health Economics Research Centre, University of Oxford, UK
Health Policy Plan 19:302-9. 2004..b>Technology transfer is one way to improve specialist skills whilst at the same time reducing the burden of disease...
- Technology transfer of Sabin-IPV to new developing country marketsHans Kreeftenberg
Netherlands Vaccine Institute NVI, Antonie van Leeuwenhoeklaan 11, 3720 AL Bilthoven, The Netherlands
Biologicals 34:155-8. 2006..This paper discusses the approach followed and the experience already gained in the project, as well as factors critical to its success...
- Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant proteinMairead Looby
Pfizer Ireland Pharmaceuticals, Grange Castle International Business Park, Dublin 22, Ireland
Biotechnol Prog 27:1718-29. 2011....
- Auto-disable syringes for immunization: issues in technology transferJ S Lloyd
World Health Organization, Geneva, Switzerland
Bull World Health Organ 77:1001-7. 1999..The present article examines factors influencing technology transfer, including feasibility, corporate interest, cost, quality assurance, intellectual property considerations, ..
- Accomplishing technology transfer: case-based lessons of what works and what does notJoseph P Lane
Rehabilitation Research and Training Center on Technology Transfer, University at Buffalo, Buffalo, New York 14214, USA
Assist Technol 15:69-88. 2003This paper presents lessons drawn from technology transfer case studies that address the persistent question: "What works, what does not, and why?" Each lesson highlights critical factors determining success or failure and is ..
- Health innovation networks to help developing countries address neglected diseasesCarlos M Morel
Center for Technological Development in Health, Oswaldo Cruz Foundation FIOCRUZ, Avenida Brasil 4365, Rio de Janeiro, RJ 21040 900, Brazil
Science 309:401-4. 2005..Here we highlight a complementary and increasingly important means to improve health equity: the growing ability of some developing countries to undertake health innovation...
- WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transferMartin Friede
World Health Organization, Avenue Appia, 1211 Geneva, Switzerland
Vaccine 29:A2-7. 2011..g. those that allow significant dose-sparing. To this end, the influenza vaccine technology transfer initiative was launched in 2007 and, to date, vaccine manufacturers in 11 developing countries have ..
- Technology transfer from worms and flies to vertebrates: transposition-based genome manipulations and their future perspectivesLajos Mátés
Max Delbruck Center for Molecular Medicine, Robert Rössle Str, 13092 Berlin, Germany
Genome Biol 8:S1. 2007....
- Information technology in complex health services: organizational impediments to successful technology transfer and diffusionF C Southon
Fujitsu Centre, University of New South Wales, Caringbah, Australia
J Am Med Inform Assoc 4:112-24. 1997..To identify impediments to the successful transfer and implementation of packaged information systems through large, divisionalized health services...
- Technology transfer pathways and livelihood impact indicators in central EthiopiaA Tesfaye
Holetta Research Center, Addis Ababa Ethiopia 4 Villardi Consulting, Singapore Correspondence E mail com sg
Trop Anim Health Prod 37:101-22. 2005..The results showed that there are many opportunities for group dissemination by making use of existing social networks. There are also opportunities for dissemination through extension agents, farmer groups and radio broadcasting...
- Technology transfer through performance management: the effects of graphical feedback and positive reinforcement on drug treatment counselors' behaviorM E Andrzejewski
Department of Psychology, Temple University, Weiss Hall 265 66, Philadelphia, PA 19122, USA
Drug Alcohol Depend 63:179-86. 2001..Nonetheless, present results show promise that feedback and positive reinforcement could be used to improve technology transfer of behavioral interventions into community clinic settings.
- Can patents deter innovation? The anticommons in biomedical researchM A Heller
University of Michigan Law School, Ann Arbor, MI 48109 1215, USA
Science 280:698-701. 1998..Otherwise, more intellectual property rights may lead paradoxically to fewer useful products for improving human health...
- Translational research: a case historyHelen Pearson
Nature 453:846-9. 2008
- Technology transfer: U.S. scientists faulted on biotech consultingJocelyn Kaiser
Science 304:1222. 2004
- Training substance abuse treatment organizations to adopt evidence-based practices: the Addiction Technology Transfer Center of New England Science to Service LaboratoryDaniel D Squires
Addiction Technology Transfer Center of New England and Brown University Center for Alcohol and Addiction Studies, Brown University, Providence, RI 02912, USA
J Subst Abuse Treat 34:293-301. 2008..To help address this gap, the Addiction Technology Transfer Center of New England (ATTC-NE), located at Brown University, has adapted and implemented an organizational ..
- Technology transfer from the science of medicine to the real world: the potential role played by artificial adaptive systemsEnzo Grossi
Bracco SpA, Milan, Italy
Subst Use Misuse 42:267-304. 2007..These tools can allow a more efficient technology transfer from the science of medicine to the real world, overcoming many obstacles responsible for the present ..
- Challenges and opportunities for enhancing biotechnology and technology transfer in developing countriesLuis A Salicrup
Office of the Director Office of Technology Transfer, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20852, USA
Biotechnol Adv 24:69-79. 2006..The challenge, however, lies in defining the role of technology transfer to develop therapies for diseases prevalent in developing countries...
- Research translation: a new frontier for clinical laboratoriesMario Plebani
Department of Laboratory Medicine, University Hospital of Padova, and Center of Biomedical Research, Castelfranco Veneto TV, Italy
Clin Chem Lab Med 44:1303-12. 2006....
- A discussion of the concept of technology transfer of research-based drug "abuse" prevention and treatment interventionsZili Sloboda
Institute for Health and Social Policy, The University of Akron, Ohio, USA
Subst Use Misuse 37:1079-87. 2002..Several theoretical perspectives that have not been brought into the technology transfer discussion are mentioned, others need to be reviewed for their potential to guide further research in this ..
- Role and reality: technology transfer at Canadian universitiesTania M Bubela
School of Public Health, Department of Public Health Sciences, 3030 Research Transition Facility, University of Alberta, Edmonton, Alberta, Canada
Trends Biotechnol 28:447-51. 2010b>Technology transfer offices (TTOs) play a central role in the knowledge translation and commercialization agenda of Canadian universities...
- The federal role in drug abuse technology transfer: a history and perspectiveBarry S Brown
University of North Carolina at Wilmington, Wilmington, NC 28403, USA
J Subst Abuse Treat 22:245-57. 2002..more effective in achieving the individual and organizational behavior change needed to achieve technology transfer. Argument is made that the federal government remains the best, if not the only resource for promoting ..
- Agency context and tailored training in technology transfer: a pilot evaluation of motivational interviewing training for community counselorsJohn S Baer
Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA, USA
J Subst Abuse Treat 37:191-202. 2009....
- University-based science and biotechnology products: defining the boundaries of intellectual propertyAaron S Kesselheim
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02120, USA
JAMA 293:850-4. 2005....
- Influenza vaccine production for Brazil: a classic example of successful North-South bilateral technology transferCosue Miyaki
BioIndustrial Division, Influenza Production Laboratory, Instituto Fundação Butantan, Sao Paulo, Brazil
Vaccine 29:A12-5. 2011b>Technology transfer is a promising approach to increase vaccine production at an affordable price in developing countries...
- A technology transfer model for effective HIV/AIDS interventions: science and practiceJ M Kraft
Division of HIV AIDS Prevention Intervention Research and Support, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
AIDS Educ Prev 12:7-20. 2000..Starting with a review of diffusion of innovations and technology transfer literature, we offer a technology transfer model for HIV interventions...
- Partnerships in technology transfer. An innovative program to enhance biomedical research and global healthLuis A Salicrup
Int Microbiol 8:1-3. 2005
- Sustainable transfer of biotechnology to developing countries: fighting poverty by bringing scientific tools to developing-country partnersJosefina Coloma
Division of Infectious Diseases, School of Public Health, University of California, Berkeley, 1 Barker Hall 422, Berkeley, CA 94720 7354, USA
Ann N Y Acad Sci 1136:358-68. 2008..For 20 years, the Sustainable Sciences Institute has built scientific capacity in developing countries to recognize, prevent, and respond to the threats posed by disease...
- A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exceptionDavid C Hoffman
Cornell Law Rev 89:993-1043. 2004
- The CREATE Act: increasing costs associated with the biotech industry?Ann E Mills
Program in Ethics and Policy in Health Care, Center for Biomedical Ethics, University of Virginia School of Medicine, P O Box 800758, Charlottesville, Virginia 22908, USA
Nat Biotechnol 24:785-6. 2006..A new law intended to promote collaborative research may end up costing the biotech industry more and inhibiting innovation...
- [Malignant lymphoma competence network]A Herrmann-Frank
Kompetenznetz Maligne Lymphome, Zentrale Klinikum der Universität zu Köln
Internist (Berl) 45:429-35. 2004..Further information is presented in http://www.lymphome.de...
- Applications of optical coherence tomography to cardiac and musculoskeletal diseases: bench to bedside?Mark E Brezinski
Brigham and Women s Hospital, Department of Orthopedic Surgery, 75 Francis Street and Harvard Medical School, Boston, Massachusetts 02115, USA
J Biomed Opt 12:051705. 2007....
- Found in translation; from the laboratory to the operating room to the marketRobert L Galloway
Biomedical Engineering, Neurological Surgery, and Center for Technology Guided Therapy, Vanderbilt University, Nashville, TN, USA
Conf Proc IEEE Eng Med Biol Soc 2007:5162-5. 2007..We have faced each of the above defined translation challenges and more remain. The presentation (and paper) will cover the process of achieving that success and of lessons often painfully learned...
- [Competence network "community acquired pneumonia" (CAPNETZ). A first interim report]T Welte
Abteilung für Pneumologie und Intensivmedizin, Universitatsklinikum Magdeburg
Internist (Berl) 45:393-401. 2004..First results indicate, that new observations made in terms of symptoms, spectrum of pathogens involved, and treatment modalities will impact on the formulation of new guidelines for the management of community acquired pneumonia...
- Biotechnology products and university-based scienceGregory K Sobolski
JAMA 293:2862; author reply 2863. 2005
- [Sharing of biotechnology: contractual agreements as avant-garde]Christine Noiville
CNRS Université Paris I Panthéon Sorbonne, Centre de recherche en droit des sciences et techniques, France
Med Sci (Paris) 21:998-1001. 2005....
- Biotechnology products and university-based sciencePhilip Lempert
JAMA 293:2861-2; author reply 2863. 2005
- Intellectual property and biotechnology: the U.S. internal experience--Part IBaruch Brody
Center for Medical Ethics, Baylor College of Medicine, Houston, TX, USA
Kennedy Inst Ethics J 16:1-37. 2006..Despite these hesitations, the U.S. rejected suggested modifications. This was a mistake, and there is a need to develop a modified system that promotes more of the relevant ethical values...
- Tech transfer fails to translate into startupsStacy Lawrence
Nat Biotechnol 25:616. 2007
- Tech transfer revs upStacy Lawrence
Nat Biotechnol 24:13. 2006
- Bioengineering and translational researchYongmin Kim
IEEE Eng Med Biol Mag 24:5. 2005
- The university-promoted patent at the crossroads of the research results and immediate industrial useR Doddoli
BIOFUTURE Research Consortium in Regenerative Medicine, c o Department of Chemistry, University of Bari, Italy
Biomol Eng 24:43-6. 2007..For the latter, owing to their nature, demand that there be no wastage and cautious management thereof...
- Beyond Bayh-Dole and the Lambert Review: an initial product development and transaction model for the interface between universities and businessMichael Fernandes
Medbase LLC, 94 Gallup Road, Princeton, NJ 08540, USA
Biotechnol Genet Eng Rev 21:249-76. 2004
- Biotechnology products and university-based scienceDavid Korn
JAMA 293:2862-3; author reply 2863. 2005
- NIH licensing performance under parKen Garber
Nat Biotechnol 22:1607-8. 2004
- Intellectual property and biotechnology: the U.S. internal experience--Part IIBaruch Brody
Center for Medical Ethics, Baylor College of Medicine, Houston, TX, USA
Kennedy Inst Ethics J 16:105-28. 2006..In each of these cases, the modifications might be more responsive to the full set of relevant values...
- Technology transfer across industriesDavid Woodley
Technograph Microcircuits Ltd, Portsmouth, UK
Med Device Technol 15:18-21. 2004..Although these are typically outside the core competence of most medical product developers, partnering with a specialist manufacturer can offer rapid access...
- Technology transfer: seeking a more efficient wayJ M Wilkinson
Technology for Industry Ltd, Ely, UK
Med Device Technol 17:36, 38-9. 2006..A wide cultural gap persists between the two and an effective means of partnering is required. This review looks at current solutions and recent progress...
- Cluster formation as a tool for development in Medicon ValleyStina Gestrelius
Medicon Valley Academy, Orestad City, Copenhagen S, Denmark
IEEE Eng Med Biol Mag 25:102-5. 2006
- Innovation and the medical devices Farady partnershipM Tavakoli
Medical Devices Faraday Partnership, TWI Ltd, Great Abington, Cambridge, UK
Med Device Technol 16:32-5. 2005..The services it offers medical device manufacturers are outlined here...
- [Systemic inflammatory rheumatic diseases competence network]C Rufenach
Geschäftsführerin im Kompetenznetz Rheuma, Deutsches Rheumaforschungszentrum Berlin
Internist (Berl) 45:409-14. 2004..The primary objective of this collaboration is to transfer new scientific insights more rapidly in order to improve methods for diagnosis and patients treatment...
- Value creation and sharing among universities, biotechnology and pharmaMark G Edwards
Recombinant Capital, 2033 N Main St, Walnut Creek, CA 94596, USA
Nat Biotechnol 21:618-24. 2003
- Harvard turns to matchmaking to speed translational researchMeredith Wadman
Nat Med 14:697. 2008
- University research. Steering Harvard toward collaborative scienceAndrew Lawler
Science 321:190-2. 2008
- Science and the law. Working through the patent problemJohn P Walsh
Department of Sociology, University of Illinois at Chicago, Chicago, IL 60607 7140, USA
Science 299:1021. 2003
- CASH 2021: commercial access and space habitationAndrew Aldrin
Students of the International Space University Summer Session Program 2001, Bremen, Germany
Acta Astronaut 51:637-46. 2002..A broad range of commercially viable opportunities, not only within the current limits of the International Space Station, but also among the many new developments that are expected by 2021 are discussed...
- The changing norms of the life sciencesPeter Shorett
Council for Responsible Genetics, Cambridge, MA 02140, USA
Nat Biotechnol 21:123-5. 2003
- Historical essay. Prospects for the futureRobert C Gallo
Institute of Human Virology and Department of Microbiology and Immunology, University of Maryland, Baltimore, MD 21201, USA
Science 298:1730-1. 2002
- Genomics and global health: time for a reappraisalDavid J Weatherall
Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford, OX3 9DS, UK
Science 302:597-9. 2003....
- The rice genome. World poverty and hunger--the challenge for scienceIsmail Serageldin
Library of Alexandria, Bibliotheca Alexandrina, Shatby, Alexandria 21526, Egypt
Science 296:54-8. 2002
- The rice genome. The cereal of the world's poor takes center stageRonald P Cantrell
International Rice Research Institute IRRI, DAPO Box 7777, Metro Manila, Philippines
Science 296:53. 2002
- South Korea. Institute helps spread use of vaccines in AsiaMark Russell
Science 295:611-2. 2002
- Medical innovation and institutional interdependence: rethinking university-industry connectionsAnnetine C Gelijns
College of Physicians and Surgeons and School of Public Health, Columbia University, 600 W 168th St, Seventh Floor, New York, NY 10032, USA
JAMA 287:72-7. 2002..medical innovation depends on extensive interactions between universities and industry, with knowledge and technology transfer flowing in both directions. These interactions have had important public health and economic benefits...
- Protecting rights to early-stage technologyMichael J Shuster
Fenwick and West LLP, 275 Battery Street, San Francisco, CA 94111, USA
Nat Biotechnol 21:701-3. 2003
- Knowledge systems for sustainable developmentDavid W Cash
John F Kennedy School of Government, Harvard University, 79 John F Kennedy Street, Cambridge, MA 02138, USA
Proc Natl Acad Sci U S A 100:8086-91. 2003..Effective systems apply a variety of institutional mechanisms that facilitate communication, translation and mediation across boundaries...
- [Chronic inflammatory bowel diseases competence network ]U R Folsch
1 Medizinische Universitätsklinik, Klinikum der Christian Albrechts Universität Kiel
Internist (Berl) 45:402-8. 2004....
- [HIV/AIDS competence network research group presents first results]N H Brockmeyer
Sprecher des Kompetenznetz HIV AIDS, Klinik für Dermatologie und Allergologie, Ruhr Universitat Bochum
Internist (Berl) 45:422-8. 2004..The establishment of a patient cohort is linked to 20 projects. The success of this new structure is becoming visible...
- [Hepatitis (Hep-Net) competence network]H Wedemeyer
Kompetenznetz Hepatitis, c o Medizinische Hochschule Hannover
Internist (Berl) 45:415-21. 2004..Further, basic questions in the fields of epidemiology, virology and immunology are processed in cooperative research projects within the network...
- A US perspective on technology transfer: the changing role of the universityLita L Nelsen
Technology Licensing Office, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139 4307, USA
Nat Rev Mol Cell Biol 5:243-7. 2004
- Lowering the barriers inherent in translating advances in neuroimage analysis to clinical research applicationsSonia Pujol
Harvard Medical School, Department of Radiology, L1 050, Brigham and Women s Hospital, 75 Francis Street, Boston MA 02115, USA
Acad Radiol 15:114-8. 2008....
- Invention and business performance in the tissue-engineering industryNitin Pangarkar
School of Business, Faculty of Engineering, National University of Singapore, Singapore
Tissue Eng 9:1313-22. 2003..We also argue that, to achieve commercial success, firms need to manage time to market (through alliances or otherwise), have a global outlook, nurture their financial resources, and attain critical mass through mergers...
- Information transfer from the USA and Europe to Latin America: current need and suitable methodsAnneliese Fischer Thom
Eur J Nucl Med Mol Imaging 30:1073-5. 2003
- Biotechnology and sustainability: the role of transatlantic cooperation in research and innovationAlfredo Aguilar
Head of Unit Biotechnologies, Research Directorate General, European Commission, Brussels, Belgium
Trends Biotechnol 26:163-5. 2008....
- Commercializing nanotechnologyLaura Mazzola
Excellin Life Sciences, 755 East Capitol Avenue 0201, Milpitas, California 95035, USA
Nat Biotechnol 21:1137-43. 2003
- China steps up US biotech intellectual property land grabMark Ratner
Nat Biotechnol 26:141-2. 2008
- The international translational regenerative medicine centerMardi de Veuve Alexis
International Translational Regenerative Medicine Center, Beckman Research Institute at City of Hope, CA, USA
Regen Med 7:74-5. 2012....
- Lessons learned from the Apple storesHenry Pinkney
J Med Pract Manage 27:307-8. 2012..This article will discuss the services provided by Apple, Inc., and how medical practices can learn from this industry giant and improve the services that they offer patients...
- Informatics technology mimics ecology: dense, mutualistic collaboration networks are associated with higher publication ratesMARCO D SORANI
Department of Neurological Surgery, University of California San Francisco, San Francisco, California, United States of America
PLoS ONE 7:e30463. 2012..There are rapidly changing trends in external technological and macroeconomic influences. We propose that a better understanding of how technologies are adopted can facilitate their development...
- A critical view of current state of phytotechnologies to remediate soils: still a promising tool?Héctor M Conesa
Departamento de Ciencia y Tecnología Agraria, Universidad Politecnica de Cartagena, Paseo Alfonso XIII, 48 30203 Cartagena, Spain
ScientificWorldJournal 2012:173829. 2012..Valuable biomass includes timber, bioenergy, feedstock for pyrolosis, biofortified products, or ecologically important species...
- Health research systems: promoting health equity or economic competitiveness?Bridget Pratt
Michael Kirby Centre for Public Health and Human Rights, Monash University, Alfred Centre Campus, 99 Commercial Road, Melbourne, Vic, 3004, Australia
Bull World Health Organ 90:55-62. 2012..e. health policy and systems research. Governments must restructure their research laws and policies to increase this essential research in developing countries...
- Universities urged to do more for poor nationsErika Check
Nature 444:412-3. 2006
- Systems biology driven software design for the research enterpriseJohn Boyle
Institute for Systems Biology, 1441 N 34th Street, Seattle, WA 98103, USA
BMC Bioinformatics 9:295. 2008..As scientists work in isolated groups, integration with other groups is rarely a consideration when building the required software tools...
- Cultural innovations and demographic changePeter J Richerson
Department of Environmental Science and Policy, University of California Davis, Davis, CA 95616, USA
Hum Biol 81:211-35. 2009....
- Those to change, those never to changeEiji Kanehira
Minim Invasive Ther Allied Technol 16:139-40. 2007
- Concepts and tools to exploit the potential of bacterial inclusion bodies in protein science and biotechnologyPietro Gatti-Lafranconi
Department of Biochemistry, University of Cambridge, Cambridge, UK
FEBS J 278:2408-18. 2011..We also review the major biophysical methods available for revealing fine structural details of aggregated proteins and which information can be obtained through these techniques...
- Relationships with industry: critical for new technology or an unnecessary evil?Joshua J Jacobs
Rush University Medical Center, Chicago, IL 60612, USA
J Bone Joint Surg Am 88:1650-63. 2006
- Current trends in antimicrobial agent research: chemo- and bioinformatics approachesRiadh Hammami
STELA Dairy Research Center, Nutraceuticals and Functional Foods Institute, Universite Laval, Quebec, QC, Canada
Drug Discov Today 15:540-6. 2010..This article reviews progress in the development of computational methods, tools and databases used for organizing and extracting biological meaning from antimicrobial research...
- Clinical peptidomic analysis by a one-step direct transfer technology: its potential utility for monitoring of pathophysiological status in female reproductive system disordersYoshihiko Araki
Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan Department of Obstetrics and Gynecology, Juntendo University Graduate School of Medicine, Tokyo, Japan
J Obstet Gynaecol Res 39:1440-8. 2013..In addition, we refer to the potential utility of this approach for the monitoring of pathophysiological status in female reproductive system disorders in general. ..
- University spin-offs: opportunity or challenge?Xiaogang Peng
Department of Chemistry and Biochemistry, University of Arkansas, 348 Arkansas Avenue, Fayetteville, Arkansas 72701, USA
Nat Mater 5:923-5. 2006
- The genome projects: implications for dental practice and educationJ T Wright
Department of Pediatric Dentistry, School of Dentistry, University of North Carolina, Chapel Hill 27599, USA
J Dent Educ 66:659-71. 2002..Oral health care practitioners will increasingly require knowledge of human genetics and the application of new molecular-based diagnostic and therapeutic technologies...
- [Consequence of intellectual property and consortium project in neurosurgery]Osamu Honmou
Department of Neurosurgery, Sapporo Medical University School of Medicine, Japan
No Shinkei Geka 32:571-7. 2004
- Thoracic sonography for pneumothorax: the clinical evaluation of an operational space medicine spin-offAndrew W Kirkpatrick
Foothills Medical Centre, Calgary, Alberta, Canada Andrew
Acta Astronaut 56:831-8. 2005..Applied thoracic US is an example of a clinically useful space medicine spin-off that is improving health care on earth...
- PROMOTING TRANSLATIONAL DENTAL RESEARCH ACADEMIC CAREERSEDWARD ROSSOMANDO; Fiscal Year: 2008..research are only partially offered through these awards, and education in entrepreneurship, management and technology transfer are not specifically provided...
- Workshop Course to Promote and Develop Dental TechnologyEDWARD ROSSOMANDO; Fiscal Year: 2004..recommendation concerning the development of competency in research management, entrepreneurship and the technology transfer process...
- Brief Family-Based Therapy for Adolescent Drug AbuseHoward Liddle; Fiscal Year: 2004..The study could produce one of the first brief, family-based therapies for adolescent drug abusers and yield findings that would have significant implications for technology transfer efforts.
- Training Strategies for Motivational InterviewingSteve Martino; Fiscal Year: 2005..abstract_text> ..
- Economic Evaluation of Adolescent Drug ServicesHoward Liddle; Fiscal Year: 2003..In accord with recommended strategies for economic evaluation studies of health care interventions, we propose to examine outcomes from two important perspectives: 1) societal and 2) state policy makers. ..
- CENTER FOR TREATMENT RESEARCH ON ADOLESCENT DRUG ABUSEHoward Liddle; Fiscal Year: 2003..This collaboration has yielded an integrative perspective on core challenges to the field which we have formed into this proposal. ..
- Training Clinicians in Empirically Based Family TherapyHoward Liddle; Fiscal Year: 2006DESCRIPTION (provided by applicant): Emerging technology transfer research in drug abuse treatment and related fields suggests that the adoption of empirically supported treatments in community programs may be greatly facilitated with ..
- Computer Assisted System for Patient Assessment/ReferralDeni Carise; Fiscal Year: 2008..There are two parts to the technology transfer: a computer-assisted ASI assessment to improve the identification and prioritization of patients' ..
- Type 1 Diabetes Genetics ConsortiumStephen Rich; Fiscal Year: 2007..The Consortium will gain a better understandingof disease mechanisms, with a purpose of altering these mechanisms and pathways in individualsat risk of type 1 diabetes. ..
- Reducing Harm to Patients from Diagnostic ErrorsETA BERNER; Fiscal Year: 2007..To leverage AHRQ funding, additional support will be provided by registration fees, vendors, non-profit organizations and in-kind logistic support from the Society for Medical Decision Making. [unreadable] [unreadable] [unreadable]..
- Optical Coherence Tomography for Pulmonary CirculationMark Brezinski; Fiscal Year: 2005..Development of an OCT Imaging Catheter, Aim 2. Assessing the Pulmonary Veins Ablation in an Animal Model, Aim 3. Vascular Assessments In Vitro, Aim 4. OCT Elastography and Aim 5. OCT Imaging will be performed in an Animal Model of PTN. ..
- Optical Coherence Tomography for Microsurgical GuidanceMark Brezinski; Fiscal Year: 2005..Use structural, polarization, and spectroscopic data to identify sensor vs motor nerves, and 7. guide epineural nerve repair with OCT guidance. ..
- HIV Risk Reduction for Women with Incarcerated PartnersOlga Grinstead; Fiscal Year: 2005..abstract_text> ..
- FLEX TM microPET/SPECT/CT to Support Cancer Research at Harvard Medical SchoolJOHN FRANGIONI; Fiscal Year: 2006..unreadable] [unreadable] [unreadable]..
- Psychotherapy Enhancement for TC RetentionSamuel Ball; Fiscal Year: 2004....
- Adapting a Medical Self-Management Program for a Community Mental Health CenterBenjamin Druss; Fiscal Year: 2008..If successful, it will provide a sustainable, scalable model for improving medical self-management in a highly vulnerable population. ..
- Development and Evaluation of Context Tailored TrainingJOHN BAER; Fiscal Year: 2006..Based on concepts of technology transfer, change in practice behavior is seen as more likely in response to training that is tailored to the ..
- A Phase 1 Study of CCI-779 in Combination with Imatnib *RANDALL HOLCOMBE; Fiscal Year: 2006..Since deregulated kinase activity is known to contribute to a wide range of malignancies, these studies will have applicability to cancer therapy in general. [unreadable] [unreadable]..
- TRANSFERRING DRUG ABUSE TREATMENT AND ASSESSMENT RESOURCD Simpson; Fiscal Year: 2008..abstract_text> ..
- ALIGNMENT BASED METHODS FOR MOLECULAR SEQUENCE ANALYSISSteven Henikoff; Fiscal Year: 2001..This effort could yield new eukaryotic family members of great importance for understanding epigenetic phenomena, some of which, such as parental imprinting, are relevant to human disease. ..
- CNS METABOLIC CORRELATES OF HIV DEMENTIA BY MRS IMAGINGMartin Pomper; Fiscal Year: 2001..abstract_text> ..
- CANCER AND LEUKEMIA GROUP B--PET COMMITTEEMark Ratain; Fiscal Year: 2002..Since many of the studies include analysis of pharmacological specimens, the Committee utilizes three core laboratories--at the University of Chicago, the University of Maryland and the University of Tennessee. ..
- Hip Fracture Evaluation Alternatives of Total Hip vs Hemi-arthroplasty (HEALTH)Thomas Einhorn; Fiscal Year: 2009..Potential Impact: This trial will not only change current orthopaedic practice, but will set a benchmark for the conduct of future orthopaedic trials. ..
- DEPRESSIVE DISORDERS IN PRIMARY CARE AND WORK SETTINGSBenjamin Druss; Fiscal Year: 2003..This project will compare the impact of depression and three chronic medical illnesses on health costs, absenteeism and job performance ratings both cross-sectionally and over time. ..
- Objective Flap Assessment During Reconstructive SurgeryJOHN FRANGIONI; Fiscal Year: 2009..With the completion of these studies, we foresee being able to solve major clinical problems in reconstructive surgery using real-time, intraoperative objective assessment. ..
- HEALTH RELATED INTERVENTIONS FOR PERSONS LIVING WITH HIVMARY ROTHERAM BORUS; Fiscal Year: 2004..abstract_text> ..
- Acquisition of an electrospray TOF mass spectrometerIGOR KALTASHOV; Fiscal Year: 2004..The operation of the instrument will be overseen by a Mass Spectrometry Advisory committee comprised of faculty members representing three academic departments and one interdisciplinary research center at UMass. ..
- Client and Counselor Attitudes Toward MedicationDennis McCarty; Fiscal Year: 2003..Aim 4. Test the impact of persuasion messages on medication usage attitudes, beliefs, normative beliefs, and attentions among both clients and counselors. ..
- GENOMIC ANALYSIS OF STRESS AND INFLAMMATIONMASON FREEMAN; Fiscal Year: 2004..abstract_text> ..
- A Depth-resolved Voltage Sensitive Dye Imaging SystemElizabeth Hillman; Fiscal Year: 2007..The effects of abnormal pathologies on neurovascular coupling could provide new insights for treatment and prevention. The new system could also find applications in ocular, dermal, endoscopic and tumor imaging. [unreadable] [unreadable]..
- Advanced Techniques for Assessing Osteoarthritis in RatsMark Brezinski; Fiscal Year: 2008..3. Examining the Combination of OCT with the Microawl Therapeutic Technique in a Surgical Rat Model of OA. 4. Examining the Combination of OCT with a Pharmaceutical Intervention in Surgical Rat Model of OA. ..
- Molecular Mechanisms of Skeletal RepairThomas Einhorn; Fiscal Year: 2008..Successful establishment and implementation of this program will greatly enhance the coordinated activities of this team of investigators and lead to important new results and directions for skeletal healing research. ..
- Mentor Mothers: A Sustainable Family Intervention in South African TownshipsMary J Rotheram Borus; Fiscal Year: 2010..The intervention's impact will be assessed over 15 months in a design that is a blend of an efficacy and effectiveness trial. ..
- Training Drug Treatment Providers to Adopt Evidence-Based PracticesDANIEL SQUIRES; Fiscal Year: 2008..provided by applicant): This project will evaluate a dissemination model developed by the Addiction Technology Transfer Center of New England (ATTCNE) to promote the adoption and utilization of evidence-based treatments for ..
- Phenotype and Gene Expression in Odontogenic TumorsJOHN T WRIGHT; Fiscal Year: 2010..Gene data will be placed on our web site in a timely fashion for data sharing. These studies will provide the first detailed mutational and gene profile studies of human odontogenic tumors. ..
- Adoption of Buprenorphine in an HMO SettingDennis McCarty; Fiscal Year: 2009..Aim 3: Identify factors that facilitate and inhibit the adoption and use of buprenorphine through interviews with 530 patients and 96 practitioners and administrators. ..
- PSMA-based PET Ligands for Prostate Cancer ImagingMartin Pomper; Fiscal Year: 2007..unreadable] [unreadable] [unreadable]..
- PSMA-based SPECT Tracers for Prostate Cancer ImagingMartin Pomper; Fiscal Year: 2007..unreadable] [unreadable]..
- IMPROVING THE DIAGNOSTIC POTENTIAL OF OCT FOR VULNERABLEMark Brezinski; Fiscal Year: 2002..abstract_text> ..
- MOLECULAR IMAGING OF ADVANCED BLADDER CANCERJOHN FRANGIONI; Fiscal Year: 2002..We believe that bladder cancer-specific, low-molecular weight ligands will someday be clinically useful reagents for improved detection and guided therapy of transitional cell carcinoma of the bladder. ..
- INTERVENTIONS FOR SUBSTANCE USING YOUTH LIVING WITH HIVMARY ROTHERAM BORUS; Fiscal Year: 2002....
- Wnt Signaling in IBD-Related Colon CancerRANDALL HOLCOMBE; Fiscal Year: 2005..The precise effects of FIPs on Wnt signaling will be defined in vitro, with attention to the potentially disparate responses of different, specific, Fz receptor subtypes. ..
- Integration Difusion for SMI Service DeliveryKIMBERLEY ISETT; Fiscal Year: 2005..Analysis will be completed using repeated measures regression techniques. ..
- First International Biocurator MeetingSeung Rhee; Fiscal Year: 2006..unreadable] [unreadable] [unreadable]..
- Near-Infrared Quantum Dots for In Vivo ImagingJOHN FRANGIONI; Fiscal Year: 2006..If completed, the specific aims of this proposal will generate a clinically useful set of contrast agents, and a more complete understanding of the in vivo behavior of fluorescent semiconductor nanocrystals. [unreadable] [unreadable]..
- Targeted Social Network HIV Prevention InterventionYuri Amirkhanian; Fiscal Year: 2007..This research, if successful, will provide a model that can be used to focus HIV prevention efforts on community population segments in greatest need. ..
- MODIFYING GENE DETERMINANTS OF TOOTH AND BONE PHENOTYPESJohn Wright; Fiscal Year: 2007..abstract_text> ..
- Maintenance of blocks-based tools for functional genomicSteven Henikoff; Fiscal Year: 2006..These various components will be packaged to facilitate updates and local implementations. [unreadable] [unreadable]..
- MOTHERS LIVING WITH HIV AND THEIR ADOLESCENT CHILDRENMARY ROTHERAM BORUS; Fiscal Year: 2007..abstract_text> ..
- NEUROTOXICITY OF METHYLMERCURY ACROSS THE LIFESPANM Newland; Fiscal Year: 2005..Items 2-4 will be conducted as adults and 3-4 to 30 months of age. At death Hg and either Se or FA profiles will be determined, depending on the cohort. ..
- Enhancement of informed consent in dental clinical trialJ Goodson; Fiscal Year: 2003..abstract_text> ..
- I-Talk: Eye Controlled, Direct Selection AAC DeviceGREGORY LESHER; Fiscal Year: 2002..abstract_text> ..
- Mechanism & Efficacy of Assessing Osteoarthritis by OCTMark Brezinski; Fiscal Year: 2009..5. In patients undergoing microfracture during arthroscopy for the treatment of localized OA, OCT imaging will be performed of adjacent articular cartilage. ..
- Understanding Disability Among The ElderlyDavid Cutler; Fiscal Year: 2005....
- PSMA-based Gene Reporter-Probe System(RMI)Martin Pomper; Fiscal Year: 2008..unreadable] [unreadable]..
- Organizational Change to Improve Access and RetentionDennis McCarty; Fiscal Year: 2009..abstract_text> ..
- Identification and Treatment Of Unstable Plaque with OCTMark Brezinski; Fiscal Year: 2009..In addition, we will in parallel attempt to further improve the rabbit hemorrhagic plaque model by inducing angiogenesis, the factor which may ultimately be the trigger of many plaque ruptures. ..
- A Pilot Survey to Measure Disability in the Elderly PopulationDavid Cutler; Fiscal Year: 2006..This research is critical for researchers, and for policy-makers who seek to understand why disability is changing and what implications those changes will have for longevity and medical spending. ..
- The role of copy number variants (CNV) in type 1 diabetesStephen Rich; Fiscal Year: 2009..Identification of genetic risk factors for T1D is the first step in risk prediction, intervention and developing disease therapeutics (prevention). ..
- LOW-MOLECULAR WEIGHT LIGANDS FOR PROSTATE CANCERJOHN FRANGIONI; Fiscal Year: 2003..We believe that prostate- specific, low-molecular weight ligands will someday be clinically useful reagents for improved prostate cancer detection and guided therapy. ..